Would you offer systemic therapy for BCLC Stage C HCC (portal vein invasion) following local therapy with Y90?

BCLC stage C HCC includes patients with advanced diseases with symptoms and/or invasive pattern by vascular invasion or extrahepatic spread. These patients are eligible for palliative treatments including systemic therapy in a standard of care setting or clinical trial.

For consideration of systemic ...